Cargando…

Effect of Angiotensin II on Chondrocyte Degeneration and Protection via Differential Usage of Angiotensin II Receptors

The renin–angiotensin system (RAS) controls not only systemic functions, such as blood pressure, but also local tissue-specific events. Previous studies have shown that angiotensin II receptor type 1 (AT(1)R) and type 2 (AT(2)R), two RAS components, are expressed in chondrocytes. However, the angiot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishida, Takashi, Akashi, Sho, Takigawa, Masaharu, Kubota, Satoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430521/ https://www.ncbi.nlm.nih.gov/pubmed/34502113 http://dx.doi.org/10.3390/ijms22179204

Ejemplares similares

Expression of Angiotensin II Receptor-1 in Human Articular Chondrocytes
por: Kawakami, Yuki, et al.
Publicado: (2012)

Activating types 1 and 2 angiotensin II receptors modulate the hypertrophic differentiation of chondrocytes()
por: Tsukamoto, Ichiro, et al.
Publicado: (2013)

Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
por: Zhang, Chao, et al.
Publicado: (2021)

Regulatory mechanism of CCN2 production by serotonin (5-HT) via 5-HT(2A) and 5-HT(2B) receptors in chondrocytes
por: Hori, Ayaka, et al.
Publicado: (2017)

Circulating angiotensin II deteriorates left ventricular function with sympathoexcitation via brain angiotensin II receptor
por: Shinohara, Keisuke, et al.
Publicado: (2015)

Differential Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on COVID-19
por: Su, Lianjiu, et al.
Publicado: (2021)

Effect of Statins, Metformin, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin II Receptor Blockers on Age-Related Macular Degeneration
por: Lee, Hyesung, et al.
Publicado: (2019)

Angiotensin II Type 1 Receptor‐Associated Protein Regulates Kidney Aging and Lifespan Independent of Angiotensin
por: Uneda, Kazushi, et al.
Publicado: (2017)

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19
por: Moore, Graham J., et al.
Publicado: (2021)

The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
por: Moretti, Myla E., et al.
Publicado: (2012)

Angiotensin II Peptides
por: Izumi, Yasukatsu, et al.
Publicado: (2013)

Angiotensin-(1-9) ameliorates pulmonary arterial hypertension via angiotensin type II receptor
por: Cha, Seung Ah, et al.
Publicado: (2018)

Angiotensin 1-7 Protects against Angiotensin II-Induced Endoplasmic Reticulum Stress and Endothelial Dysfunction via Mas Receptor
por: Murugan, Dharmani, et al.
Publicado: (2015)

Angiopoietin-like protein 2 expression is suppressed by angiotensin II via the angiotensin II type 1 receptor in rat cardiomyocytes
por: Wang, Shuya, et al.
Publicado: (2016)

Angiopoietin-like protein 2 expression is suppressed by angiotensin II via the angiotensin II type 1 receptor in rat cardiomyocytes
por: Wang, Shuya, et al.
Publicado: (2020)

Angiotensin II modulates THP-1-like macrophage phenotype and inflammatory signatures via angiotensin II type 1 receptor
por: Barhoumi, Tlili, et al.
Publicado: (2023)

Angiotensin II potentiates zinc-induced cortical neuronal death by acting on angiotensin II type 2 receptor
por: Park, Mi-Ha, et al.
Publicado: (2013)

Effects of moderate-intensity endurance exercise on angiotensin II and angiotensin II type I receptors in the rat heart
por: Li, Xin, et al.
Publicado: (2017)

Eprosartan mesylate, an angiotensin II receptor antagonist
por: Qian, Jing-Jing, et al.
Publicado: (2011)

Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists
por: Vasile, Silvana, et al.
Publicado: (2020)

Roles of Interaction between CCN2 and Rab14 in Aggrecan Production by Chondrocytes
por: Hoshijima, Mitsuhiro, et al.
Publicado: (2020)

Pneumonia Risk and Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
por: Liu, Chia-Lin, et al.
Publicado: (2013)

Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
por: Lee, Hyun Woo, et al.
Publicado: (2021)

Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers
por: Holloway-Kew, Kara L., et al.
Publicado: (2022)

Correction: Angiotensin 1-7 Protects against Angiotensin II-Induced Endoplasmic Reticulum Stress and Endothelial Dysfunction via Mas Receptor
por: Murugan, Dharmani, et al.
Publicado: (2016)

Angiotensin II promotes the anticoagulant effects of rivaroxaban via angiotensin type 2 receptor signaling in mice
por: Yang, Dan, et al.
Publicado: (2017)

Angiotensin II for the treatment of vasodilatory shock: enough data to consider angiotensin II safe?
por: Buchtele, Nina, et al.
Publicado: (2018)

Deletion of the angiotensin II type 1 receptor–associated protein enhances renal sodium reabsorption and exacerbates angiotensin II–mediated hypertension
por: Ohsawa, Masato, et al.
Publicado: (2014)

Angiotensin II type 1 receptor blockers favorably affect renal angiotensin II and MAS receptor expression in patients with diabetic nephropathy
por: Ma, Ye-Ping, et al.
Publicado: (2020)

Angiotensin II Type 1 Receptor-associated Protein Inhibits Angiotensin II-induced Insulin Resistance with Suppression of Oxidative Stress in Skeletal Muscle Tissue
por: Ohki, Kohji, et al.
Publicado: (2018)

Angiotensin II in septic shock
por: Corrêa, Thiago D, et al.
Publicado: (2015)

Role of angiotensin II in aging
por: Yi, Wenmin, et al.
Publicado: (2022)

Angiotensin 1-7 Receptor and Angiotensin II Receptor 2 Blockades Prevent the Increased Serum and Kidney Nitric Oxide Levels in Response to Angiotensin II Administration: Gender-Related Difference
por: Safari, Tahereh, et al.
Publicado: (2013)

Angiotensin Converting Enzyme and Angiotensin II Type 1 Receptor Polymorphisms in Patients with Coronary Aneurysms
por: Lamblin, Nicolas, et al.
Publicado: (2003)

Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
por: Jun, Hye-Ran, et al.
Publicado: (2021)

Differential brain angiotensin-II type I receptor expression in hypertensive rats
por: Braga, Valdir A.
Publicado: (2011)

Attenuation of Angiotensin II–Induced Hypertension in BubR1 Low‐Expression Mice Via Repression of Angiotensin II Receptor 1 Overexpression
por: Aoyagi, Yukihiko, et al.
Publicado: (2019)

SAT-562 Angiotensin II Induces Aldosterone Synthesis in the Rat Heart Stressed by Angiotensin II
por: Bose, Himangshu S, et al.
Publicado: (2020)

Effects of Endogenous Angiotensin II on Abdominal Aortic Aneurysms and Atherosclerosis in Angiotensin II–Infused Mice
por: Kukida, Masayoshi, et al.
Publicado: (2021)

Angiotensin II centrally induces frequent detrusor contractility of the bladder by acting on brain angiotensin II type 1 receptors in rats
por: Kawamoto, Bunya, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jshvp8bf5pr4hnm0fbstk55ntr